HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuki Hashimoto Selected Research

White Dot Syndromes

5/2016Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy.
9/2015Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome.
1/2015Multiple evanescent white dot syndrome associated with retinal vasculitis.
11/2014Retinal outer layer thickness increases with regression of multiple evanescent white dot syndrome and visual improvement positively correlates with photoreceptor outer segment length.
1/2012Increased macular choroidal blood flow velocity during systemic corticosteroid therapy in a patient with acute macular neuroretinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuki Hashimoto Research Topics

Disease

7Neoplasms (Cancer)
03/2022 - 06/2015
7Pruritus (Itching)
06/2007 - 07/2004
6Dermatitis
10/2011 - 09/2003
6Atopic Dermatitis (Atopic Eczema)
10/2011 - 07/2004
5Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
08/2019 - 04/2015
5Inflammation (Inflammations)
11/2016 - 11/2004
5White Dot Syndromes
05/2016 - 01/2012
3Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022 - 05/2017
3Adenocarcinoma
04/2019 - 05/2017
3Neoplasm Metastasis (Metastasis)
01/2019 - 09/2011
2Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2019
2Acute zonal occult outer retinopathy
10/2021 - 03/2014
2Ganglion Cysts (Ganglion)
09/2021 - 03/2015
2Leukemia
12/2016 - 05/2005
2Calcinosis
06/2015 - 06/2015
2Atrophy
01/2015 - 01/2012
2Respiratory Hypersensitivity
12/2010 - 01/2010
1Pigmented Nevus (Melanocytic Nevus)
01/2022
1Sepsis (Septicemia)
01/2022
1Stomach Neoplasms (Stomach Cancer)
12/2021
1Leukocytosis (Pleocytosis)
09/2021
1Retinal Detachment (Retinal Detachments)
01/2021
1Pain (Aches)
01/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021
1Viremia
11/2020
1Microaneurysm
08/2020
1Macular Edema
08/2020
1Telangiectasis (Telangiectasia)
12/2019
1Macular Degeneration (Age-Related Maculopathy)
12/2019
1Uveitis
08/2019
1Carcinoma (Carcinomatosis)
04/2019
1Necrosis
01/2019
1Dysgeusia (Parageusia)
01/2019
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2019
1Retinal Hemorrhage
12/2018
1Wound Infection (Wound Infections)
01/2018
1Acute Liver Failure (Fulminant Hepatic Failure)
12/2017
1Wounds and Injuries (Trauma)
06/2017
1Acute Promyelocytic Leukemia
12/2016
1Triple Negative Breast Neoplasms
06/2016
1Central Serous Chorioretinopathy
10/2015
1Breast Neoplasms (Breast Cancer)
06/2015
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
03/2015
1Retinal Vasculitis
01/2015

Drug/Important Bio-Agent (IBA)

12Retinaldehyde (Retinal)IBA
10/2021 - 01/2012
7Adrenal Cortex Hormones (Corticosteroids)IBA
08/2019 - 06/2007
6ProstaglandinsIBA
06/2007 - 11/2004
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2021 - 01/2012
3Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2018
3AntigensIBA
01/2019 - 01/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2007 - 09/2003
2Biological ProductsIBA
03/2022 - 05/2017
2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2008
2AntibodiesIBA
10/2021 - 08/2019
2Immunoglobulin E (IgE)IBA
10/2011 - 12/2004
2Pharmaceutical PreparationsIBA
06/2007 - 02/2007
2Therapeutic UsesIBA
02/2007 - 11/2004
2Tacrolimus (Prograf)FDA LinkGeneric
02/2007 - 09/2003
2Prostaglandin D2IBA
02/2007 - 11/2004
2Prostaglandins DIBA
11/2006 - 08/2006
2Prostaglandins EIBA
11/2006 - 05/2005
1brodalumabIBA
03/2022
1Omeprazole (Prilosec)FDA LinkGeneric
01/2022
1encorafenibIBA
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1NivolumabIBA
12/2021
1Complement System Proteins (Complement)IBA
10/2021
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
10/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1Estrogens (Estrogen)FDA Link
12/2019
1Perilipin-2IBA
04/2019
1Indicators and Reagents (Reagents)IBA
04/2019
1polaprezinc (Z 103)IBA
01/2019
1Irinotecan (Camptosar)FDA LinkGeneric
01/2019
1Simendan (Levosimendan)IBA
01/2019
1Panitumumab (Vectibix)FDA Link
01/2019
1CarbohydratesIBA
01/2019
1InterleukinsIBA
01/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1FlagellinIBA
01/2018
1LipopolysaccharidesIBA
12/2017
1GalactosamineIBA
12/2017
1Paclitaxel (Taxol)FDA LinkGeneric
05/2017
1GemcitabineFDA Link
05/2017
1Messenger RNA (mRNA)IBA
12/2016
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
12/2016
1Estrogen ReceptorsIBA
06/2016
1Progesterone Receptors (Progesterone Receptor)IBA
06/2016
1Phenobarbital (Luminal)FDA Link
06/2015
1Mitochondrial DNA (mtDNA)IBA
03/2015

Therapy/Procedure

8Therapeutics
12/2021 - 08/2007
6Lasers (Laser)
06/2017 - 03/2014
4Drug Therapy (Chemotherapy)
11/2020 - 05/2017
2Palliative Care (Palliative Therapy)
01/2022 - 01/2021
2Vitrectomy
01/2015 - 02/2014
1Colectomy
03/2022
1Adjuvant Chemotherapy
12/2021
1Neoadjuvant Therapy
06/2015